CRISPR/Cas9 knockout of human arylamine N-acetyltransferase 1 in MDA-MB-231 breast cancer cells suggests a role in cellular metabolism

অনুরূপ উপাদানগুলি

• Knockout of Human Arylamine N-Acetyltransferase 1 (NAT1) in MDA-MB-231 Breast Cancer Cells Leads to Increased Reserve Capacity, Maximum Mitochondrial Capacity, and Glycolytic Reserve Capacity
  অনুযায়ী: Carlisle, Samantha M., অন্যান্য
  প্রকাশিত: (2018)
• Untargeted polar metabolomics of transformed MDA-MB-231 breast cancer cells expressing varying levels of human arylamine N-acetyltransferase 1
  অনুযায়ী: Carlisle, Samantha M, অন্যান্য
  প্রকাশিত: (2016)
• Genetic and Small Molecule Inhibition of Arylamine N-acetyltransferase 1 Reduces Anchorage-Independent Growth in Human Breast Cancer Cell Line MDA-MB-231
  অনুযায়ী: Stepp, Marcus W., অন্যান্য
  প্রকাশিত: (2018)
• Effect arylamine N-acetyltransferase 1 on morphology, adhesion, migration, and invasion of MDA-MB-231 cells: role of matrix metalloproteinases and integrin αV
  অনুযায়ী: Li, Pengcheng, অন্যান্য
  প্রকাশিত: (2020)
• Plasmid-based CRISPR-Cas9 system efficacy for introducing targeted mutations in CD81 gene of MDA-MB-231 cell line
  অনুযায়ী: Kasra Arbabi Zaboli, অন্যান্য
  প্রকাশিত: (2022-03-01)